Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wilfried E. Eberhardt"'
Autor:
Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P. Fendler, Christoph Rischpler, Kaid Darwiche, Wilfried E. Eberhardt, Lale Umutlu, Dirk Theegarten, Martin Stuschke, Martin Schuler, Clemens Aigner, Ken Herrmann, Till Plönes
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Background Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression, LCNEC demonstrates an increa
Externí odkaz:
https://doaj.org/article/084f39ecd15a4dfbbb4deb425b97b489
Autor:
Claudia Alexandra Dumitru, Agnes eBankfalvi, Xiang eGu, Wilfried E. Eberhardt, Reinhard eZeidler, Stephan eLang, Sven eBrandau
Publikováno v:
Frontiers in Immunology, Vol 4 (2013)
CORTACTIN is an actin-binding protein critically involved in cellular migration and invasion. Here, we investigated the role of CORTACTIN in the pathophysiology of orohypopharynx carcinoma – one of the major subtypes of head and neck cancer. To thi
Externí odkaz:
https://doaj.org/article/4aadbe7f86e847bc83d4ace38d6a6c8b
Publikováno v:
Innere Medizin (Heidelberg, Germany)Literatur. 63(7)
Treatment concepts for patients with localized and locally advanced non-small cell lung cancer (NSCLC) are based on local treatment, surgery and/or radiotherapy, with curative intent. An adjuvant systemic treatment is added after primary resection of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f237802d48b793590b19b76c60d8eac3
https://pubmed.ncbi.nlm.nih.gov/35925268
https://pubmed.ncbi.nlm.nih.gov/35925268
Autor:
Matthias Scheffler, Marcel Wiesweg, Sebastian Michels, Lucia Nogová, Anna Kron, Thomas Herold, Andreas H. Scheel, Martin Metzenmacher, Wilfried E. Eberhardt, Henning Reis, Jana Fassunke, Kaid Darwiche, Clemens Aigner, Diana Schaufler, Richard Riedel, Rieke Fischer, Sophia Koleczko, Hans-Ulrich Schildhaus, Sabine Merkelbach-Bruse, Kurt W. Schmid, Reinhard Büttner, Jürgen Wolf, Martin Schuler
Rebiopsies of non-small cell lung cancers (NSCLC) are mainly performed to (i) cover the evolution of potentially amenable resistance mechanisms against a targeted therapy, and (ii) to identify new therapeutic targets which were not detected in the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1857c7f126a4c8f0e9c5d467dd7a443
https://www.ncbi.nlm.nih.gov/pubmed/35461051
https://www.ncbi.nlm.nih.gov/pubmed/35461051
Autor:
Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P Fendler, Christoph Rischpler, Kaid Darwiche, Wilfried E Eberhardt, Lale Umutlu, Dirk Theegarten, Martin Stuschke, Martin Schuler, Clemens Aigner, Ken Herrmann, Till Plönes
Background:Large cell neuroendocrine carcinomas of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression LCNEC demonstrates an increased gluco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b40ec55bc0d34ad5d358ff63ae28d88f
https://doi.org/10.21203/rs.3.rs-513428/v1
https://doi.org/10.21203/rs.3.rs-513428/v1
Autor:
Martin, Metzenmacher, Moritz, Goetz, Thomas, Herold, Martin, Stuschke, Clemens, Aigner, Kaid, Darwiche, Wilfried E, Eberhardt, Martin, Schuler, Marcel, Wiesweg
Publikováno v:
Clinical lung cancer. 22(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71267659feb7f4e3d4a7c189c76dcc91
https://pubmed.ncbi.nlm.nih.gov/33551244
https://pubmed.ncbi.nlm.nih.gov/33551244